Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gurpreet Kapoor"'
Autor:
Erika Klohe, Sunil Suchindran, Gurpreet Kapoor, Jimson D'Souza, Ellie Corigleano, Dejka Araujo, Sandra D'Angelo
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f20c7914d505425c02a4007b3d16f1c
https://doi.org/10.1136/jitc-2022-sitc2022.0600
https://doi.org/10.1136/jitc-2022-sitc2022.0600
Autor:
Gurpreet Kapoor, Stefan Zajic, Sunil Suchindran, Jaegil Kim, Uma Saxena, Aishwarya Bhaskar, Heather Kaczynski, Michael Nathenson, Jimson D'Souza, Benjamin Rich, Sandra D'Angelo, Mihaela Druta, Brian Van Tine, Neeta Somaiah, David Liebner, Scott Schuetze, Ioanna Eleftheriadou
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50e345a61468fc594a656a5c54b5a416
https://doi.org/10.1136/jitc-2022-sitc2022.0601
https://doi.org/10.1136/jitc-2022-sitc2022.0601
Autor:
James E. Hoffman, Taiga Nishihori, Michael Chisamore, Stefan Zajic, Jonathan L. Kaufman, Sunil Suchindran, Aaron P. Rapoport, Charlotte Snape, Anne Huff, Gurpreet Kapoor, Amit Jain
Publikováno v:
Blood. 138:3865-3865
Background: Outcomes remain poor for patients with relapsed and refractory multiple myeloma (RRMM) progressing on conventional therapy (proteasome inhibitors, IMiDs, anti-CD38 antibodies, BCMA targeting agents, corticosteroids). Lete-cel, an autologo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8e4dae75804f51c0b6c6a03a95ced29
https://doi.org/10.1182/blood-2021-153004
https://doi.org/10.1182/blood-2021-153004
Autor:
Gurpreet Kapoor, Sunil Suchindran, Scott M. Schuetze, Mihaela Druta, Jaegil Kim, Neeta Somaiah, Stefan Zajic, Ioanna Eleftheriadou, Brian A. Van Tine, Michael Nathenson, David A. Liebner, Sandra P. D'Angelo, Anne Huff
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A424-A424
BackgroundThis is an open label pilot study (NCT02992743) on letetresgene autoleucel (lete-cel; GSK3377794), an NY-ESO-1-specific autologous CD4+ and CD8+ T cells expressing a high affinity T-cell receptor which recognizes the NY-ESO-1 antigen epitop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::030bffae1a3b847e03d1dae1810ca9a4
https://doi.org/10.1136/jitc-2021-sitc2021.391
https://doi.org/10.1136/jitc-2021-sitc2021.391
Autor:
Mihaela Druta, Andrew P. Holmes, Stefan Zajic, Scott M. Schuetze, Anne Huff, Aisha N. Hasan, Brian A. Van Tine, Neeta Somaiah, Gurpreet Kapoor, David A. Liebner, Sandra P. D'Angelo
Publikováno v:
Journal of Clinical Oncology. 39:11521-11521
11521 Background: Cancer testis antigen NY-ESO-1 is expressed in multiple tumor types, including 80‒90% of MRCLS [1,2]. Overall response rates (ORRs) to MRCLS treatment are low (1L, 2 fludarabine [flu] x 3d + 600 mg/m2 cyclophosphamide [cy] x 3d) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30ca341f328c59de0dec607386f47142
https://doi.org/10.1200/jco.2021.39.15_suppl.11521
https://doi.org/10.1200/jco.2021.39.15_suppl.11521
Autor:
Gurpreet Kapoor, Weimin Li, Willie Underwood, Olesya Chornoguz, Mary-Ellen Taplin, Jennifer Phillips, Tracy McGowan, Charles J. Ryan, Philip W. Kantoff, E. David Crawford, Neal D. Shore, Dong Shen
Publikováno v:
Cancer Research. 78:LB-212
IMAAGEN is a phase 2, multicenter study evaluating 1000 mg abiraterone acetate + 5 mg prednisone (AAP) for the treatment of patients (pts) with high risk non-metastatic castration-resistant prostate cancer (nmCPRC). This study has been ongoing since
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61a6f911fd189eea3a72a4a6335f057f
https://doi.org/10.1158/1538-7445.am2018-lb-212
https://doi.org/10.1158/1538-7445.am2018-lb-212
Autor:
Gerhardt Attard, Gurpreet Kapoor, Fabio Calabrò, Weibke Arlt, Anna Wingate, Daniel Wetterskog, Bertrand F. Tombal, Cora N. Sternberg, Weimin Li, Lorraine Barwell, Michael Gormley, Axel S. Merseburger, Florence Lefresne, Dong Shen, Robert Jones, Susan Feyerabend, Alfredo Berruti, Mansour T. A. Sharabiani, Anuradha Jayaram
Publikováno v:
Journal of Clinical Oncology. 36:5067-5067
5067Background: pAR gene aberrations in mCRPC patients (pts) may be associated with worse outcome on AA+P/D. Methods: This was an international, multi-institutional, open-label phase 2 study of AA ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9917fbe9693af3b17aeeb50b1312495f
https://doi.org/10.1200/jco.2018.36.15_suppl.5067
https://doi.org/10.1200/jco.2018.36.15_suppl.5067
Autor:
Gurpreet Kapoor, Timothy Gocke, Sanjeev Chawla, Robert Whitmore, Ali Nabavizadeh, Joanna Lopinto, Justin Plaum, Eileen Maloney-Wilensky, Harish Poptani, Elias Melhem, Kevin Judy, Donald O’Rourke
Publikováno v:
Journal of Neuro-Oncology; May2009, Vol. 92 Issue 3, p373-386, 14p